Eltrombopag with gemcitabine‐based chemotherapy in patients with advanced solid tumors: a randomized phase I studyEric S. Winer, Yasser Mostafa Kamel, Bhabita Mayer et al.|Cancer Medicine|2014Cited by 63
A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancersRobert M. Brody, Devraj Basu, David Shimunov et al.|Oral Oncology|2022Cited by 16
Safety and efficacy of eltrombopag (epag) versus placebo (pbo) for the treatment (tx) of chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors receiving gemcitabine (gem)-based chemotherapy (ctx): A phase I study.Eric S. Winer, Yasser Mostafa Kamel, Howard Safran et al.|Journal of Clinical Oncology|2012Cited by 5
Outcomes and prediction of lethal recurrence after transoral robotic surgery for HPV+ head and neck cancer.Devraj Basu, Robert M. Brody, David Shimunov et al.|Journal of Clinical Oncology|2021Cited by 2